26270904|t|Nanotheranostics: Congo Red/Rutin-MNPs with Enhanced Magnetic Resonance Imaging and H2O2-Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice.
26270904|a|As nanotheranostics, Congo red/Rutin-MNPs combine the abilities of diagnosis and treatment of Alzheimer's disease (AD). The biocompatible nanotheranostics system based on iron oxide magnetic nanoparticles, with ultrasmall size and excellent magnetic properties, can specifically detect amyloid plaques by magnetic resonance imaging, realize targeted delivery of AD therapeutic agents, achieve drug controlled release by H2O2 response, and prevent oxidative stress.
26270904	18	27	Congo Red	Chemical	MESH:D003224
26270904	28	33	Rutin	Chemical	MESH:D012431
26270904	84	88	H2O2	Chemical	MESH:D006861
26270904	111	130	Alzheimer's Disease	Disease	MESH:D000544
26270904	159	163	Mice	Species	10090
26270904	186	195	Congo red	Chemical	MESH:D003224
26270904	196	201	Rutin	Chemical	MESH:D012431
26270904	259	278	Alzheimer's disease	Disease	MESH:D000544
26270904	280	282	AD	Disease	MESH:D000544
26270904	336	346	iron oxide	Chemical	MESH:C000499
26270904	451	466	amyloid plaques	Disease	MESH:D058225
26270904	527	529	AD	Disease	MESH:D000544
26270904	585	589	H2O2	Chemical	MESH:D006861
26270904	Negative_Correlation	MESH:D012431	MESH:D000544
26270904	Negative_Correlation	MESH:D003224	MESH:D000544
26270904	Negative_Correlation	MESH:C000499	MESH:D000544
26270904	Association	MESH:D006861	MESH:D000544
26270904	Association	MESH:C000499	MESH:D058225

